Home » Topics » Nephrology, BioWorld Science

Nephrology, BioWorld Science
RSS

Dual CB1R/iNOS antagonist MRI-1867 ameliorates obesity-induced CKD in vivo

Sep. 27, 2019

Senolytics work as advertised

Sep. 25, 2019

Finding a balance in treating diabetic kidney damage

Sep. 23, 2019

Novel glomerulus-on-a-chip for renal disease modeling and drug testing

Sep. 23, 2019

A1M reports initial phase Ia data on ROSgard

Sep. 20, 2019

Xortx reports promising phase II data with TMX-049 in type 2 diabetic nephropathy

Sep. 20, 2019

Design of novel zebrafish models of cystinosis

Sep. 16, 2019

Phase III AMPLIFY study of phosphate absorption inhibitor tenapanor meets primary endpoint

Sep. 4, 2019

Eli Lilly and Company describes PDE1 inhibitors

Sep. 3, 2019

Discovery and preclinical evaluation of SH-379 as a novel anti-LOH agent

Aug. 22, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 8, 2026.
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Infensa Bioscience identifies new ASIC blockers
BioWorld Science
Infensa Bioscience Pty Ltd. has patented new acid-sensing ion channel 1 (ASIC) blockers potentially useful for the treatment of stroke, among others.
Kymera’s IRF5 degrader shows potential in IBD treatment
BioWorld Science
At the recently concluded Digestive Disease Week, researchers from Kymera Therapeutics Inc. presented preclinical efficacy data on KT-579, a selective oral IRF5...
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...